A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
- Status
- RECRUITING
- Phase
- PHASE3
Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE3
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
- Status
- RECRUITING
- Phase
- PHASE2
Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- NA
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
DK222 Study at Hopkins
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2